## Purpose A novel transdermal formulation of granisetron (the granisetron transdermal delivery system (GTDS)) has been developed to deliver granisetron continuously over 7ย days. This double-blind, phase III, non-inferiority study compared the efficacy and tolerability of the GTDS to daily oral gra
โฆ LIBER โฆ
Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability
โ Scribed by H. G. Prentice
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 193 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Efficacy and tolerability of transdermal
โ
Ralph V. Boccia; Lucio N. Gordan; Gemma Clark; Julian D. Howell; Steven M. Grunb
๐
Article
๐
2010
๐
Springer-Verlag
๐
English
โ 185 KB
Granisetron in the control of radiothera
โ
Petra Feyer; M. Heinrich Seegenschmiedt; Maria Steingraeber
๐
Article
๐
2005
๐
Springer-Verlag
๐
English
โ 157 KB
The anti-emetic efficacy and tolerabilit
โ
Reuven Or; Pavlos Drakos; Arnon Nagler; Elizabeth Naparstek; Joseph Kapelushnik;
๐
Article
๐
1994
๐
Springer-Verlag
๐
English
โ 356 KB
Plasma exchange and vincristine in the t
โ
Victor A. Silva; Debra Frei-Lahr; Randy A. Brown; Geoffrey P. Herzig
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 457 KB
Hemolytic uremic syndrome/thrombotic thrornbocytopenic purpura (HUSITTP) is a rare and often fatal complication of bonc marrow transplantation (BMT). In this study. wc rcport eight such cases (seven allo and onc auto) treated with plasma exchanges (PE), vincristine (six paticnts), and discontinuatio